Using computer-aided detection software to help find target areas in images may result in readers missing areas not marked for viewing.
Using computer-aided detection (CAD) software to help find target areas in images may actually result in readers missing areas not marked for viewing, according to research published in the October issue of Academic Radiology.
Researchers performed two experiments as part of an eye-tracking study to determine eye movements as images were being read. Forty-seven observers with an average age of 24.3 years examined images for the targets, which were the letter “T.” Throughout the image, there were also several marks of the letter “L.”
The first experiment provided high noise and low similarity between the targets, meant to cause distraction and making the targets more difficult to locate. The second experiment used less distraction and provided more targets, making the targets easier to find.
Researchers found that although in the first experiment, observers were able to find many of the targets, guided by the CAD, this came at a cost: If targets were not in an area marked by the CAD, they were likely not located. For the second experiment, there was no noted behavioral benefit from CAD, but neither was there a cost in missed targets as there was in the first experiment.
In evaluating eye movements, the researchers saw that the CAD observers looked at a lower total area than did the non-CAD observers.
“CAD signals do not combine with observers' unaided performance in a straightforward manner,” concluded the authors. “CAD can engender a sense of certainty that can lead to incomplete search and elevated chances of missing unmarked stimuli.”
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.